Recommendations for observational studies of comorbidity in multiple sclerosis
Citation Manager Formats
Make Comment
See Comments

Abstract
Objective: To reach consensus about the most relevant comorbidities to study in multiple sclerosis (MS) with respect to incidence, prevalence, and effect on outcomes; review datasets that may support studies of comorbidity in MS; and identify MS outcomes that should be prioritized in such studies.
Methods: We held an international workshop to meet these objectives, informed by a systematic review of the incidence and prevalence of comorbidity in MS, and an international survey regarding research priorities for comorbidity.
Results: We recommend establishing age- and sex-specific incidence and prevalence estimates for 5 comorbidities (depression, anxiety, hypertension, hyperlipidemia, and diabetes); evaluating the effect of 7 comorbidities (depression, anxiety, hypertension, diabetes, hyperlipidemia, chronic lung disease, and autoimmune diseases) on disability, quality of life, brain atrophy and other imaging parameters, health care utilization, employment, and mortality, including age, sex, race/ethnicity, socioeconomic status, and disease duration as potential confounders; harmonizing study designs across jurisdictions; and conducting such studies worldwide. Ultimately, clinical trials of treating comorbidity in MS are needed.
Conclusion: Our recommendations will help address knowledge gaps regarding the incidence, prevalence, and effect of comorbidity on outcomes in MS.
GLOSSARY
- CI=
- confidence interval;
- EDSS=
- Expanded Disability Status Scale;
- ICD=
- International Classification of Diseases;
- MS=
- multiple sclerosis;
- NARCOMS=
- North American Research Committee on Multiple Sclerosis
Footnotes
Go to Neurology.org for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the article. The Article Processing Charge was paid by the National Multiple Sclerosis Society and the European Committee for Treatment and Research in Multiple Sclerosis.
Coinvestigators are listed on the Neurology® Web site at Neurology.org.
See page 1437
Supplemental data at Neurology.org
- Received September 11, 2015.
- Accepted in final form January 7, 2016.
- © 2016 American Academy of Neurology
This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND), which permits downloading and sharing the work provided it is properly cited. The work cannot be changed in any way or used commercially.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Hastening the Diagnosis of Amyotrophic Lateral Sclerosis
Dr. Brian Callaghan and Dr. Kellen Quigg
► Watch
Topics Discussed
Alert Me
Recommended articles
-
Article
Sex differences in comorbidity at diagnosis of multiple sclerosisA population-based studyRuth Ann Marrie, Scott B. Patten, Helen Tremlett et al.Neurology, March 09, 2016 -
Views & Reviews
The challenge of comorbidity in clinical trials for multiple sclerosisRuth Ann Marrie, Aaron Miller, Maria Pia Sormani et al.Neurology, February 17, 2016 -
Article
Comorbidity in multiple sclerosis is associated with diagnostic delays and increased mortalityAnja Thormann, Per Soelberg Sørensen, Nils Koch-Henriksen et al.Neurology, September 20, 2017 -
Article
Effects of physical comorbidities on disability progression in multiple sclerosisTingting Zhang, Helen Tremlett, Feng Zhu et al.Neurology, January 03, 2018